Jill Roberts Center for Inflammatory Bowel Disease

Publications

Found 8 results
Author Title [ Type(Asc)] Year
Filters: First Letter Of Title is P  [Clear All Filters]
Journal Article
Poppers DM, Scherl EJ.  2008.  Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care.. Inflamm Bowel Dis. 14(1):106-13.
Battat R, Long MD.  2021.  Is Proactive Therapeutic Drug Monitoring Ready for the Spotlight in Inflammatory Bowel Disease? Follow the Data. Am J Gastroenterol. 116(10):2029-2031.
Longman RS, Talal AH, Jacobson IM, Albert ML, Rice CM.  2004.  Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.. Blood. 103(3):1026-9.
Lukin DJ.  2020.  Predictors of Perianal Fistula Relapse in Crohn's Disease.. Inflamm Bowel Dis. 26(6):932-933.
Shmidt E, Kochhar G, Hartke J, Chilukuri P, Meserve J, Chaudrey K, Koliani-Pace JL, Hirten R, Faleck D, Barocas M et al..  2018.  Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.. Inflamm Bowel Dis. 24(11):2461-2467.
Decalf J, Fernandes S, Longman R, Ahloulay M, Audat F, Lefrerre F, Rice CM, Pol S, Albert ML.  2007.  Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients.. J Exp Med. 204(10):2423-37.
Ghosh G, Jacob V, Wan D.  2018.  Plasmablastic Lymphoma in a Patient With Crohn's Disease After Extensive Immunosuppressive Therapy.. Clin Gastroenterol Hepatol. 16(4):e41-e42.
Shen T-CDavid, Lebwohl B, Verma H, Kumta N, Tennyson C, Lewis S, Scherl E, Swaminath A, Capiak KM, DiGiacomo D et al..  2012.  Peripheral neuropathic symptoms in celiac disease and inflammatory bowel disease.. J Clin Neuromuscul Dis. 13(3):137-45.